Mycobacterium tuberculosis ClpP Proteases Are Co-transcribed but Exhibit Different Substrate Specificities by Personne, Y et al.
Mycobacterium tuberculosis ClpP proteases are co-transcribed but exhibit
different substrate specificities
Personne, Y; Brown, AC; Schuessler, DL; Parish, T
 
 
 
 
 
 
 
For additional information about this publication click this link.
http://qmro.qmul.ac.uk/jspui/handle/123456789/5201
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
Mycobacterium tuberculosis ClpP Proteases Are Co-
transcribed but Exhibit Different Substrate Specificities
Yoann Personne, Amanda C. Brown, Dorothe´e L. Schuessler, Tanya Parish*
Queen Mary University of London, Barts & The London School of Medicine and Dentistry, London E1 2AT, United Kingdom
Abstract
Caseinolytic (Clp) proteases are widespread energy-dependent proteases; the functional ATP-dependent protease is
comprised of multimers of proteolytic and regulatory subunits. Mycobacterium tuberculosis has two ClpP proteolytic
subunits (ClpP1 and ClpP2), with both being essential for growth in vitro. ClpP1 and clpP2 are arranged in an apparent
operon; we demonstrated that the two genes are co-expressed under normal growth conditions. We identified a single
promoter region for the clpP1P2 operon; no promoter was detected upstream of clpP2 demonstrating that independent
expression of clpP1 and clpP2 was highly unlikely. Promoter activity was not induced by heat shock or oxidative stress. We
identified a regulatory region upstream of the promoter with a consensus sequence matching the ClgR regulator motif; we
determined the limits of the region by mutagenesis and confirmed that positive regulation of the promoter occurs in M.
tuberculosis. We developed a reporter system to monitor ClpP1 and ClpP2 enzymatic activities based on LacZ incorporating
ssrAtag sequences. We showed that whilst both ClpP1 and ClpP2 degrade SsrA-tagged LacZ, ClpP2 (but not ClpP1)
degrades untagged proteins. Our data suggest that the two proteolytic subunits display different substrate specificities and
therefore have different, but overlapping roles in M. tuberculosis.
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Introduction
Tuberculosis is a major health problem causing approximately
1.5 million deaths each year, with one-third of the world’s
population estimated to be infected [1]. The genome of
Mycobacterium tuberculosis, the main causative agent for tuberculosis,
encodes 142 proteases [2] including FtsH, the proteasome and the
Clp proteases.
Caseinolytic proteases (Clp) are highly conserved serine
proteases present in a wide range of bacteria as well as in plants
and mammals [3]. Clp are two-component proteases comprising
of a catalytic subunit (ClpP) and a regulatory subunit (Clp
ATPase). The catalytic subunit is composed of two heptameric
rings of ClpP stacked on top of each other forming a cavity where
protein degradation occurs.
M. tuberculosis contains two clpP genes, clpP1 and clpP2, both
essential for growth [4–6]. Furthermore, a knockdown strain of
ClpP1P2 showed reduced growth in vitro and lack of replication
after infection of macrophages [4]. Unusually, M. tuberculosis ClpP1
and ClpP2 can interact to form an active proteolytic complex
composed of one ring of ClpP1 and one ring of ClpP2 [6,7]. The
ClpP1 structure was resolved and displays a unique N-terminal
configuration [8]. In M. tuberculosis, ClpP1 and ClpP2 are highly
expressed in both aerobic and hypoxic environments [9]. Diamide,
a thiol-oxidative agent, and vancomycin may induce clpP1 and
clpP2 expression in M. tuberculosis and M. smegmatis respectively
[10,11].
A novel class of compounds, the acyldepsipeptides (ADEPs), are
active against M. tuberculosis and also have potent activity against
various Gram positive bacteria, including multidrug resistant
isolates such as methicilin-resistant Staphylococcus aureus (MRSA)
[5,12,13]. Unusually the ADEPs do not act as inhibitors, but
induce unregulated proteolysis by ClpP which recognises and
degrades unfolded polypeptides and ultimately results in cell death
[14].
ClgR is a transcriptional activator of clpC and clpP1P2 gene
expression in Corynebacterium glutamicum and Streptomyces lividans
[15,16]. Rv2745c, the M. tuberculosis ClgR homologue, binds
upstream of clpP1P2 and activates transcription in M. tuberculosis
[17]. Deletion of ClgR results in a reduced capacity to replicate in
macrophages [18]. Moreover ClgR, as well as the two ClpP
proteases, are involved in the reaeration response: they have been
found to be induced during the transition of M. tuberculosis from
bacteriostasis to growth [17].
The presence of two ClpP subunits in M. tuberculosis is unusual
and intriguing. We are interested in finding the regulation
mechanisms controlling their expression and demonstrated a
common regulation but different specificities for the two ClpP
subunits.
Materials and Methods
Culture
M. tuberculosis H37Rv was cultured in Middlebrook 7H9 liquid
medium supplemented with 10% v/v OADC (oleic acid, bovine
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serum albumin, dextrose, catalase; Becton Dickinson) or AD (5%
w/v bovine serum albumin, 2% w/v glucose) and 0.05% w/v
Tween 80, or Dubos liquid medium supplemented with 10% v/v
Dubos medium albumin (Becton Dickinson) and 0.05% w/v
Tween 80 (DTA) or on Middlebrook 7H10 agar supplemented
with 10% v/v OADC. For LacZ reporter system experiments M.
tuberculosis was grown in 7H9 medium supplemented with 10% v/v
BSA, 0.1% w/v succinate and 0.05% w/v Tween 80 plus 0.1% w/
v acetamide where indicated. Streptomycin was used at 40 mg/mL
and hygromycin at 100 mg/mL where required. Hypoxia was
generated in 20 mm sealed glass tubes containing 17 mL DTA
with stirring at 150 rpm as per the model of Wayne (head space
ratio 1:2) [19]. For reaeration, 3 mL of hypoxic cultures were used
to inoculate 100 mL of fresh medium in 450 cm2 roller bottles (5:1
head space ratio) and incubated with rolling at 37uC. Oxidative
stress was generated with 10 mM diamide, vancomycin was used
at 6 mg/mL, chlorpromazine at 50 mg/mL and menadione at
10 mg/mL.
Semi-quantitative RT-PCR
RNA was prepared from M. tuberculosis standing cultures during
late exponential phase [20] and DNAase treated. cDNA was
synthesized from 1 mg of total RNA using SuperScript II RT
(Invitrogen) and random primers. PCR was carried out using
undiluted cDNA and serial 4-fold dilutions (1:4, 1:16, 1:64, 1:256,
1:1024). Cycling conditions were 30 cycles of 94uC for 30s, 56uC
for 30s, and 72uC for 1 min using GoTaq PCR Mastermix
(Promega). SigA was used as an internal RNA control.
Construction of Plasmids and Recombinant Strains
Two regions upstream of clpP1P2 were PCR amplified (using
reverse primer AGT ACT GCT CAC AGT GGG GCA CCT
with forward primer AGT ACT TGA CCG TAT GAC GCT
GTA to create P125 or forward primer AGTA CTC AGG GCC
GCA GTG GAG GC to create P278) and cloned into the
integrating promoter reporter vector pSM128 [21]. Site directed
mutagenesis (SDM) was carried out as described [22].
Protein tags (AADENYA-ASV and AADENYA-LAA) were
added to the C-terminal end of lacZ in pSM128 by two rounds of
PCR using forward primer GGT CTG GTG TCA AAA AGC
AGC AAA CGA CGA AAA CTA CGC TTT AGC AGC TTA
ATA ATA AC and its reverse complement to add the AADENYA
core amino acid sequence, and using primers GGT CTG GTG
TCA AAA AGC ATC AGT TTA ATA ATA ACC GGG for the
ASV end and GGT CTG GTG TCA AAA ATT AGC AGC
TTA ATA ATA ACC GGG for the LAA end and their respective
reverse complements. AADENYA-ASV was mutated to AADE-
NYA-GGG by site directed mutatgenesis. The acetamidase
promoter (Pami) [23] was excised from pFLAME-3-ace [24] and
cloned into the ScaI sites of the plasmids upstream of lacZ.
Over-expressing ClpP1 and ClpP2 strains were obtained by
electroporationof therecombinantplasmidspOPPY1,pOPPY2and
pOPPY7 [5] intoM. tuberculosis and selection with hygromycin.
Promoter Activity Assays
Sequence-verified plasmids were electroporated into M. tubercu-
losis and transformants were selected on streptomycin. Three
independent transformants for each strain were grown as standing
cultures; cell-free extracts and b-galactosidase assays were
performed as described previously [25].
Results
clpP1 and clpP2 are Co-transcribed in M. tuberculosis
We wanted to determine if expression of the two ClpP subunits
of M. tuberculosis could be independently regulated and thus be
expressed under different conditions. From the genomic organi-
sation it seemed likely that clpP1 and clpP2 would be co-expressed
since they are organised in an apparent operon with overlapping
stop and start codons. In order to determine if clpP1 and clpP2 are
co-transcribed as an operon, we conducted semi quantitative RT-
PCR (Fig. 1) to identify the mRNA transcripts. Primers were
designed to amplify regions specific to clpP1 (258 bp), clpP2
(257 bp), or the clpP1-clpP2 junction (264 bp). To determine the
relative amounts of each mRNA species, limiting dilution RT-
PCR was used as a semi-quantitative method; sigA, whose
expression is considered to be constant across different conditions
was used as a control [26]. Products were identified for all three
mRNA species, indicating that the two genes are co-transcribed.
The level of expression of the co-transcript and the clpP1-specific
transcript were similar suggesting that clpP2 was not being
expressed from two promoters (since that would be expected to
lead to higher levels of clpP2 relative to clpP1). In addition, the
relative levels of amplification of the clpP2-specific transcript
derived from the 39 end of the gene were lower compared to levels
of clpP1 mRNA (and as compared to the levels of clpP1P2
transcript from the 59 end of clpP2) as expected if the gene was at
the 39 end of an operon. These data strongly suggest that clpP1 and
clpP2 are co-transcribed, in these conditions at least, under the
control of a single promoter.
Identification of the clpP1/clpP2 Promoter
Since we had confirmed co-expression of the two genes, we
wanted to identify the promoter of the operon. We cloned a
125 bp region (P125) encompassing the first two codons of M.
tuberculosis clpP1, the intergenic region between clpP1 and the
upstream gene tig, and the tig stop codon (Fig. 2A), into pSM128
[21], an integrating vector present in a single copy in the genome;
and introduced this inM. tuberculosis. pSM128 is a reporter plasmid
containing a promoterless lacZ commonly used to measure gene
expression in mycobacteria [27–29]. b-galactosidase activity was
detected in aerobic cultures (Fig. 2B) (221 MU) confirming that a
functional promoter was present in this region. To determine if
there was a second promoter for clpP2, the region encompassing
the first two codons of clpP2 and 280 bp upstream of clpP2 was also
tested, but no activity was detected (Fig. 2C). This confirms that, at
least under aerobic culture conditions, clpP2 is not independently
expressed from another promoter, so that clpP1 and clpP2 are co-
expressed from the same promoter upstream of clpP1.
Mycobacterial promoters are very diverse although the 210
element is frequently similar to the E. coli consensus sequence
(TATAAT). We identified two putative 210 elements in the
125 bp promoter region (Fig. 3A). To determine if either of these
are the genuine 210 element of the promoter, the TAGTGT
hexamer (10A) was mutated to CAGTGG and the TAGAAG
hexamer (10B) was mutated to CGGAAG and promoter activity
was measured in M. tuberculosis (Fig. 3B). No significant difference
in activity was observed when the TAGAAG hexamer was
mutated, but when the TAGTGT was mutated to CAGTGG,
promoter activity was abolished, indicating that the TAGTGT
hexamer is the 210 element of the clpP1P2 operon promoter.
Mtb ClpPs Have Different Substrate Specificities
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Promoter Activity was not Induced after Heat Shock or
Oxidative Stress
Under stress conditions such as high temperature or oxidation,
mis-folded proteins may be generated, which can further
accumulate as protein aggregates and are potentially toxic for
the cells. Clp proteases are involved in the degradation of mis-
folded or aggregated proteins [30,31] and are heat induced in
several organisms including Bacillus subtilis and C. glutamicum
[16,32]. Additionally, oxidative stress, generated by addition of
diamide, may induce clpP1P2 expression in M. tuberculosis [10]. We
tested the effect of similar stress treatments on P125 promoter
activity in M. tuberculosis. We saw no difference in P125 promoter
activity after oxidative shock or heat shock (data not shown)
indicating that the promoter was not induced by these conditions.
Identification of a Positive Regulatory Site in the
Upstream Region
Previous work had suggested that the clpP operon might be
induced in response to oxidative stress [10], although we saw no
evidence of upregulation of the promoter. We considered that the
intergenic region between clpP1 and tig might not contain all of the
regulatory sites required for induction. To test this, we cloned a
larger upstream fragment (278 bp - denoted P278) into pSM128
and measured promoter activity as before (Fig. 4A). P278 had
promoter activity 6-fold higher than the shorter sequence
suggesting that at least one binding site for a regulatory element
was missing in the shorter region. We therefore used this construct
for all other work.
Treatment with chlorpromazine, menadione, valinomycin in M.
tuberculosis [33] and vancomycin in M. smegmatis [11] have
previously been shown to increase ClpP mRNA levels. We tested
each of these potential inducers in M. tuberculosis. P278 promoter
activity was not induced or repressed in response to any of these
treatments (Fig. 4A).
We also looked at P278 promoter activity in aerobically grown
roller cultures of M. tuberculosis (Fig. 4B); once again no induction
of activity was seen. However, we did note that promoter activity
was higher in the highly aerated rolling cultures (1,380 MU)
compared to standing cultures (740 MU).
We considered the possibility that induction of clpP1P2 is strain-
specific since Mehra and Kausal (2009) used M. tuberculosis
CDC1551. P278 promoter activity was compared between M.
tuberculosis H37Rv and M. tuberculosis CDC1551 but the activity of
the CDC1551 strain (800 MU) was comparable to that observed
in H37Rv and was not induced after diamide treatment (Fig. 4C)
demonstrating that promoter induction was not strain specific.
Transcriptome profiling suggested that streptomycin exposure
might induce clpP1 and clpP2 expression [33]. Since streptomycin
was the antibiotic used to maintain selection pressure for the
reporter plasmids, there was the possibility that the lack of
induction may result from the fact that the promoter was already
induced. Therefore, we measured P278 promoter activity without
streptomycin selection and with diamide or vancomycin treat-
ments; there was no significant difference in activity confirming
that streptomycin was not pre-inducing clpP1P2 promoter activity
(Fig. 4D).
The difference in promoter activity between rolling and
standing cultures could indicate that the promoter activity is
growth dependent. P278 promoter activity was measured from
rolling aerated cultures over a time course from OD580 0.15 to 1.7.
The activity was constant from early log phase (OD580 = 0.15) to
stationary phase (OD580 = 1.5) from 720 to 980 MU (Fig. 5A).
However in late stationary phase (OD580 = 1.7 to 1.8), promoter
activity increased significantly (to 1,050 MU) compared to the
activity measured at early log phase (OD580 = 0.15) (Fig. 5A).
Figure 1. clpP1 and clpP2 are co-transcribed as an operon. A) Chromosomal organisation of clpP1 and clpP2. Regions amplified for RT-PCR are
marked. B) Limiting dilution semi-quantitiative RT-PCR. RNA was extracted from M. tuberculosis grown to late exponential phase in liquid cultures and
cDNA was synthesised from 1 mg of RNA. Serial 4- fold dilutions of cDNA were used as a template for PCR using primers specific for clpP1 (P1), clpP2
(P2), the clpP1-clpP2 junction (P1P2) and sigA. C: no RT control; B: no template blank, M: markers.
doi:10.1371/journal.pone.0060228.g001
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Promoter Activity during Hypoxia and Reaeration
M. tuberculosis has the ability to survive inside the host
environment for decades in a latent state before reactivation.
The Wayne model is frequently used to study hypoxia [34], one
condition believed to be encountered by the bacteria during
latent infection, and inoculating hypoxic cultures into aerated
medium (reaeration) can be used to mimic reactivation of the
disease [17]. P278 promoter activity was measured during
adaptation to hypoxia and over 12 weeks of survival in hypoxia
(Fig. 5B). Promoter expression was similar between aerated and
hypoxic cultures (typically around 700–800 MU) for up to 56
days (eight weeks) of hypoxia. There was no change in
expression during the adaptation phase where cells switch from
replicating into a non-replicating state. Promoter activity
remained high during this state for several weeks, but was
reduced approximately two-fold during long term hypoxia (8–12
Figure 2. Identification of the promoter of the clpP1P2 operon. A) The regions upstream of clpP1 or clpP2 tested for promoter activity are
marked. B) P125 activity in M. tuberculosis. C) PclpP2 activity in M. tuberculosis. Promoter activity was measured in transformants grown to late
exponential phase in standing liquid cultures. Results are the average activity 6 standard deviation of three independent transformants assayed in
duplicate. Activity is given in Miller Units (MU)- measured as nmol of O-nitrophenol produced per min per mg of protein. Control = pSM128 empty
vector control.
doi:10.1371/journal.pone.0060228.g002
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weeks). After 12 weeks, hypoxic cultures were inoculated into
aerated medium, and promoter activities measured once the
cultures reached OD580.0.3 (it was not possible to measure
activity in earlier cultures due to low cell numbers); promoter
activity quickly returned to the higher level after reaeration
(Fig. 5C). These data confirm that there is a small change in
expression of the operon in response to long term hypoxia,
although the relative levels of expression remained high.
Mapping of a Positive Regulator Binding Site
We found higher promoter activity using P278 as compared to
P125 suggesting that the longer fragment contained at least one
regulatory element binding site missing in the shorter fragment.
Regulation of clpP1P2 by the transcriptional activator ClgR is
highly conserved within the actinomycetes [15,16] including M.
tuberculosis [17]. In all bacteria containing ClgR the central
consensus motif CGC-N5-GCG is found upstream of clpP1P2
and clpC [35]. This motif is found in the region upstream of
clpP1P2 in M. tuberculosis, approximately 100 bp upstream from the
ClpP1 start codon (Fig. 6A). In order to determine if this was a true
ClgR motif, we mutated the first half of the motif CGC to AAA in
the P278 fusion. Promoter activity was significantly reduced after
mutation (3.4-fold reduction) suggesting the possible binding of a
regulator at this site, most likely to be ClgR (Fig. 6B).
We examined the extent of the proposed regulatory region
further. Single nucleotide substitutions were constructed where A/
T was mutated to G and C/G was replaced by A (Fig. 6C).
Twenty bases were mutated in total and numbered 1 to 20. Two
bases (A1 and C20) whose mutation had no effect on promoter
activity were considered to be outside the regulatory region.
Mutations in all of the other 18 bp (2–19) had a significant effect
on promoter activity and we therefore considered these nucleo-
tides to constitute the binding site, which is thus 18 bp long. Two
mutations resulted in a higher promoter activity (C5A and G19A)
while all other mutations resulted in a significant reduction in
promoter activity.
ClpP1 or ClpP2 Over-expression has Different
Consequences
We hypothesised that the ClpP subunits might recognise
different subsets of substrate proteins and so might play different
roles in the cell. It was recently shown that the ClpP1P2 protease
complex is required for the degradation of SsrA-tagged proteins in
M. tuberculosis, which are abnormal proteins arising in presence of
defective mRNAs [6].
The tmRNA system adds small peptide tags to proteins destined
for degradation by the Clp protease. We wanted to determine
which ClpP (or both) was responsible for the degradation of SsrA-
tagged proteins. We generated LacZ variants where SsrA tags
were fused at the C-terminal end; AANDENYA-LAA and
AANDENYA-ASV protein tags were added to LacZ (referred as
LacZ-LAA and LacZ-ASV respectively) and expressed under the
control of the inducible acetamidase promoter (Pami) from M.
smegmatis [23]. These degradation tags were previously shown to
cause different protein half-lifes [36]. LacZ activity was measured
in the wild-type background and in cells over-expressing clpP1 and
clpP2 individually or together [5].
M. tuberculosis was grown under LacZ-induced (acetamide) or
LacZ-uninduced conditions and steady state levels of LacZ protein
were measured. The steady state level reflects a balance between
protein synthesis and protein degradation, consequently if
degradation of LacZ is performed by the ClpP proteases, a strain
over-expressing the protease would have a higher protein turnover
rate and lower steady state levels.
We confirmed that the expression of LacZ was acetamide-
inducible: untagged LacZ activity was 4.1-fold higher under
Figure 3. Identification of the 210 promoter element. A) Sequence of the P125 region upstream of clpP1P2. Putative 210 elements (10A and
10B) are boxed. The residues mutated are in bold. The predicted ClpP1 start codon and Tig stop codons are indicated. B) Identification of the 210
element. The following mutations were made - 10A: TAGTGT mutated to CAGTGG; 10B: TAGAAG mutated to CGGAAG. Results are the average
activity of three independent transformants assayed in duplicate 6 standard deviation. Activity is given in Miller Units (MU)- measured as nmol of O-
nitrophenol produced per min per mg of protein. The background activity from pSM128 (control vector) was 462 MU. A significant difference,
measured by the student’s t-test (unpaired, two sided), compared to the control vector (pSM128) is marked by an *(p,0.05).
doi:10.1371/journal.pone.0060228.g003
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induced conditions in the wild-type strain (Fig. 7A); the tagged
versions were also induced (2–4 fold), although induction of LacZ-
LAA was only 2-fold. The level of LacZ-ASV was comparable to
untagged LacZ, with similar induction levels, confirming that the
tag alone did not change turnover under normal levels of ClpP
expression (Fig. 7B). Interestingly, the addition of the LAA tag
resulted in reduced steady state levels of LacZ even in the wild-
type background, suggesting that this tag is recognised by the
native ClpP protease and that degradation of LacZ-LAA is
occurring (Fig. 7C). Replacing the three terminal residues of the
tag, which are critical for recognition, resulted in loss of
degradation – the levels of LacZ were comparable to the untagged
protein (Fig. 7D).
ClpP2 Over-expression Induces Degradation of Untagged
LacZ
Clp proteases are responsible for degrading proteins tagged by
the tmRNA system, but can also degrade untagged proteins. We
looked at the effect of over-expressing either ClpP1 or Clp2, or
both. No difference in the steady state levels of untagged LacZ
activity was observed when ClpP1 was over-expressed (Fig. 7A).
However, there was a significant decrease in the steady state levels
of untagged LacZ when ClpP2 or ClpP1-ClpP2 was over-
expressed (2.3-fold and 1.6-fold reduction respectively). These
data suggest that ClpP2 is involved in degrading untagged
proteins.
ClpP1 and ClpP2 Over-expression Induce Degradation of
ASV Tagged LacZ
Incorporation of the ASV tag changed the dynamics of protein
turnover. There was a significant decrease in steady state levels of
LacZ-ASV when ClpP1 or ClpP2 were over-expressed indepen-
dently or together (1.3-fold reduction in all over-expressing strains)
(Fig. 7B). This suggests that the SsrA tag directs proteins to
degradation by both ClpP1 and ClpP2 in M. tuberculosis.
LAA Tagged LacZ is Degraded Quickly
The terminal three residues of the M. tuberculosis ssrAtag
sequence are LAA [37]. Tagging LacZ with LAA had a profound
effect on protein activity levels. A reduction in steady state
Figure 4. P278 promoter activity was not induced by stress treatments. A) P278 promoter activity in standing liquid cultures. Treatments
were: 50 mg/mL of chlorpromazine for 3 h, 10 mg/mL of menadione for 3 h, 10 mg/mL of valinomycin for 3h, 6 mg/mL of vancomycin for 90 min. B)
Promoter activity in rolling cultures. Treatments were: 42uC for 1 h, 10 mM diamide for 1 h C) Promoter activity in response to diamide treatment in
M. tuberculosis CDC1551. D) Promoter activity in response to diamide and vancomycin treatments in presence or absence of streptomycin selection.
Stress treatments were 10 mM diamide for 1 h or 6 mg/mL of vancomycin for 90 min. The average and standard deviation of three independent
transformants assayed in duplicate is given. ß-galactosidase activity is given in Miller Units - measured as nmol of O-nitrophenol produced over time
(min) per mg of protein. Activity is given in Miller Units (MU)- measured as nmol of O-nitrophenol produced per min per mg of protein. The
background activity from pSM128 (control vector) was 663 MU under the different conditions tested.
doi:10.1371/journal.pone.0060228.g004
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quantities of LacZ-LAA was seen in all strains, even in the WT as
compared to untagged LacZ (Fig. 7C); LacZ-LAA activity was
approximately 5,000 MU in induced conditions in all strains,
while untagged and LacZ-ASV activity was about 10,000 MU in
the WT strain. Since LacZ-LAA is degraded more quickly than
LacZ or LacZ-ASV, this suggests that the LAA tag is more
efficient at directing proteins into the degradation pathway. Over-
expression of ClpP1 and ClpP2 had no effect on steady state levels
of LacZ-LAA, presumably because the turnovers rates were
already at their maximum.
ClpP1 Recognises the Last Three Residues of the Tag
The E. coli ClpXP complex recognises the last three amino acids
of the ssrA tag (AANDENYALAA). To determine if the last three
amino acids of the tag were also the determinant for recognition in
mycobacteria, the last three residues were mutated to GGG.
Interestingly, the uninduced level of LacZ-GGG (7,400 MU) was
higher compared to either untagged or tagged LacZ (Fig. 7D). The
steady state levels of LacZ-GGG were similar between the wild-
type and ClpP1 over-expressing strains confirming that the protein
was not being recognised by ClpP1 for degradation and that the
ssrA tag is important for ClpP1-mediated degradation. In contrast,
LacZ-GGG steady state levels were significantly reduced when
ClpP2 was over-expressed (2.5-fold reduction) confirming that
ClpP2 degrades abundant proteins in the absence of a C-terminal
degradation signal, as also seen with the untagged protein.
Interestingly in this case, when both clpP1 and clpP2 were over-
expressed the steady state levels were unchanged.
Proteolytic Turnover is not Increased after Heat or
Oxidative Shocks
Since LacZ-ASV appeared to be a good indicator of ClpP1 and
ClpP2 activity, LacZ-ASV steady state levels were measured after
oxidative shock (addition of diamide), or vancomycin treatment in
order to determine if these conditions increased protein turnover
(Fig. 7E). M. tuberculosis transformants carrying LacZ-ASV were
grown in the presence of acetamide to induce expression and
steady state levels of LacZ were measured after stress treatments.
There was no significant difference in LacZ-ASV steady state
levels between untreated and treated cultures suggesting that
protein turnover is not increased in these conditions. As seen
before LacZ-ASV levels were reduced when ClpP1 was over-
expressed. However no increase in LacZ-ASV degradation was
observed after stress treatments, suggesting that ClpP1 activity is
not increased at the functional level.
Discussion
We were interested in determining the functional significance of
the presence of two ClpP proteases in M. tuberculosis and whether
they play different or overlapping roles in proteolytic degradation.
ClpP1 and clpP2 are co-transcribed under the control of a single
promoter, excluding the possibility they are expressed under
different conditions.
M. tuberculosis encodes 13 different putative sigma factors which
ensure promoter recognition [38]. The 210 element of the
clpP1P2 promoter was identified and this sequence matches the
consensus sequence for the binding sequence of sigma factor A, the
principal sigma factor of M. tuberculosis [39]. The 210 element
sequence of the clpP1P2 operon (TAGTGT) has three nucleotides
in common with the E. coli consensus sequence (TATAAT), and as
expected the intrinsic activity of the promoter element deprived of
regulator binding sites (92 bp) was very low (12 MU; data not
shown).
We tested the promoter constructs in related mycobacterial
species. Interestingly promoter activities were significantly higher
in M. tuberculosis compared to the model organisms M. smegmatis or
M. marinum (data not shown) often used as genetic hosts for M.
tuberculosis studies. A possible explanation for this may be the
absence of regulatory control elements in the model organisms.
Figure 5. Promoter activity during aerobic growth, hypoxia,
and reaeration in M. tuberculosis. A) M. tuberculosis transformants
harbouring P278 were grown in aerobic culture. Results are the average
activity of three transformants against average OD580. A significant
difference, measured by the student’s t-test (unpaired, two sided),
compared to promoter activity at OD580 = 0.15 is marked by an
*(p,0.05). B) P278 promoter activity in the Wayne model of hypoxia.
M. tuberculosis liquid cultures were inoculated to a theoretical starting
OD580 of 0.004 in DTA medium. A significant difference compared to
activity at day 0 is marked by an *(p,0.05) using the student’s t-test
(unpaired, two sided). C) P278 promoter activity after reaeration. Long
term hypoxic cultures (12 weeks) were used to inoculate medium and
grown in aerobic rolling cultures. Cell-free extracts were prepared once
the cultures reached an OD580 of 0.3. Results are the average activity of
three independent transformants assayed in duplicate 6 standard
deviation. Activity is given in Miller Units- measured as nmol of O-
nitrophenol produced per min per mg of protein.
doi:10.1371/journal.pone.0060228.g005
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We found that the high level expression of clpP1P2 required the
presence of a regulatory motif consistent with ClgR regulation
which might operate differently in the fast growing species.
We mapped the extent of a regulatory region for activity; the
18 bp sequence identified is an imperfect palindrome which
matches the consensus sequence of the ClgR binding site in C.
glutamicum [40]. ClgR binding upstream of clpP1P2 has been
demonstrated in M. tuberculosis [17], although the binding motif
was not characterised, strongly suggesting that this region is the
sequence where ClgR is binding. Although the regulatory region is
present in P125 and P278, the two regions had different activity,
with much higher promoter activity in the larger fragment. This
could be due to presence of a terminator in the pSM128 plasmid
close to the regulatory site which alters the binding of the regulator
in the shorter construct.
Promoter activity was slightly increased in late stationary phase
(after an OD580 of 1.7) suggesting that an increase in the Clp
protease activity may be necessary to degrade proteins no longer
required for growth. The importance of the Clp proteases in
stationary phase was previously demonstrated as E. coli and B.
subtilis clpP mutants have a loss of viability during stationary phase
survival [32,41].
Promoter activity during hypoxia was high and constant for up
to eight weeks. This is an unusual pattern of activity, since the
expression of most genes is typically down-regulated or turned off
completely during hypoxia when metabolic activity is greatly
reduced. These data are consistent with our previous report of
sustained high level expression of clpP1 and clpP2 at the mRNA
level in a hypoxic environment [9]. It is likely that there is a high
level of protein turnover during adaptation to hypoxia and the
controlled shift down to a non-replicating state and the high level
Figure 6. Identification of key residues in a regulatory region of the clpP1P2 operon. A) Sequence of the region upstream of clpP1P2. The
tig stop codon, 210 promoter element, and clpP1 start codons are underlined. The 18 nucleotides that constitute the regulatory region are boxed in
grey. The CGC region mutated is underlined in bold. B) Identification of a regulatory region. The CGC motif (underlined bold) was mutated to AAA. C)
Mapping of a regulatory binding site. Single nucleotide substitutions in P278 were made by SDM. Residues A or T were mutated to G or and residues C
or G were mutated to A. Results are the average activity of three independent transformants assayed in duplicate 6 standard deviation. Activity is
given in Miller Units- measured as nmol of O-nitrophenol produced per min per mg of protein. A significant difference of activity compared to wild-
type P278 is marked by an *(p,0.05) using the student’s t-test (unpaired, two sided).
doi:10.1371/journal.pone.0060228.g006
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Figure 7. Protein turnover in strains over-expressing ClpP subunits. A to D) M. tuberculosis transformants were grown to late exponential
phase in standing liquid cultures in presence of succinate +/2 acetamide (0.1% w/v) and cell-free extracts were prepared and b-galactosidase activity
measured. Empty bars: uninduced conditions (succinate); Grey striped bars: induced conditions (succinate+acetamide). A significant difference
measured by the student’s t-test (unpaired, two sided) compared to the induced LacZ level in the WT strain is marked by an *(p,0.05). E) Three M.
tuberculosis transformants carrying LacZ-ASV were grown to late exponential phase in standing liquid cultures in presence of acetamide (0.1% w/v)
and cell-free extracts were prepared. Treatments were 10 mM diamide for 1 h or 6 mg/mL of vancomycin for 90 min. A significant difference from
untreated WT is marked by an *(p,0.05). Results are the average activity of three independent transformants assayed in duplicate 6 standard
deviation. Activity is given in Miller Units- measured as nmol of O-nitrophenol produced per min per mg of protein. Strains are- WT: wild-type; P1:
over-expressing ClpP1; P2: over-expressing ClpP2; P1P2: over-expressing ClpP1 and ClpP2.
doi:10.1371/journal.pone.0060228.g007
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of expression of ClpP1P2 suggests an important role for the Clp
protease under these conditions.
Promoter activity was reduced between 8 to 12 weeks of hypoxia
but returnedto itsoriginalactivityquicklyafter reaerationconfirming
previous reports of clpP induction during reaeration [17].Reaeration
has been used as amodel of reactivation of latent infection; the rapid
induction of promoter activity during reaeration may suggest a role
for the Clp proteases during reactivation. Targeting Clp activity,
either directly or via ClgR, could therefore be a novel and attractive
approach topreventM.tuberculosis survivalduring infectionandavoid
reactivation of the disease.
The role of proteases is particularly vital during stresses that
increase the occurrence of damaged proteins. clpP induction under
heat shock conditions is variable among actinomycetes: while
clpP1P2 expression is induced upon severe heat stress in C.
glutamicum [16], none of the clp genes are heat induced in Steptomyces
lividans [15]. We did not detect any increase in promoter activity in
M. tuberculosis during heat shock at 42uC; this is consistent with
previous microarray studies which did not detect any induction of
clpP1 or clpP2 following heat shock [42].
We saw no induction of promoter activity after diamide or
vancomycin treatments [10,11]. Previous work had suggested that
diamide may induce clpP1P2 expression and that this was
regulated by SigH. However this study compared the expression
levels of clpP1P2 in a wild-type strain to expression levels in a sigH
deletion strain after diamide treatment (and expressed them as a
ratio). No measurement of mRNA was made in the wild-type
strain; the apparent over-expression in the wild-type strain in the
presence of diamide could instead result from under-expression in
the sigH deletion strain (since data were expressed as a ratio). The
induction by vancomycin was seen in M. smegmatis; we often see
differences in gene regulation between this non-pathogenic, fast-
growing strain and the pathogenic, slow-growing M. tuberculosis
and in fact the promoter identified in this study had different
activity between the two species, so there may be true differences
in regulation.
ClpP1 and ClpP2 play a role in protein quality control by
degrading SsrA-tagged proteins. In order to determine if a difference
in substrate recognition was seen between the two ClpP proteins,
unstable LacZ variants with different degradation tags were used.
Thefirsteightaminoacidsof thetagsweresimilar (AANDENYA)and
the last three residues differed (LAA, ASV, GGG). We used the
acetamidase promoter to generate high level expression of the
reporter LacZ, since over-expression of proteins often makes them
vulnerable toproteolytic degradation as the cells attempt tominimise
metabolic burden. No changes in LacZ levels were observed in the
non-induced conditions suggesting that degradation only occurs
when protein concentration reaches a threshold level. When ClpP1
andClpP2 were over-expressed individually or together, LacZ-ASV
steady levels were significantly reduced, demonstrating that both
ClpP1 and ClpP2 are involved in the degradation of proteins
harbouring this C-terminus tag. However, degradation was not
increased during heat or oxidative stresses.
Mutation of the last three residues of the SsrA tag prevented
recognition by ClpP1, demonstrating that these residues were the
determinant for identification. These residues are recognised by
the ClpXP complex in E. coli suggesting that ClpP1 and ClpP2 can
interact with ClpX for the degradation of SsrA-tagged proteins in
M. tuberculosis. The adaptor protein SspB recognises the AAN-
DENY portion of the tag which is different from the M. tuberculosis
sequence [44,45]. M. tuberculosis does not have a SspB homolog
[46] and ClpP1 and ClpP2 proteases recognise E. coli tag
sequences suggesting that an accessory protein may not be
necessary for degradation in M. tuberculosis as it is the case in S.
pneumoniae [47].
Interestingly, over-expression of ClpP2 led to increased
turnover of untagged LacZ demonstrating that ClpP2 can degrade
proteins independently of the tag sequence. Over-expression of
ClpP1 did not lead to increased turnover of untagged LacZ. This
difference in substrate degradation suggests that ClpP1 may be
more specific to a particular set of substrates, such as proteins
harbouring the SsrA degradation tag, as opposed to ClpP2 that
might be responsible for a general and central housekeeping
function. To function as an effective protease ClpP1 and ClpP2
associate; however the levels of ClpP1 appear higher than of
ClpP2 (Fig. 1), therefore under ClpP2 over-production conditions
the observed activity of ClpP2 may be seen due to its previous
association with ClpP1.
Clp ATPases are the subunits involved in substrate recognition
implying that the difference in substrate specificities displayed by
the two ClpP proteases is likely to result from ClpP1 and ClpP2
interacting with different ATPase subunit(s). As both ClpX and
ClpC1 are present in M. tuberculosis an attractive model would be
that ClpX could interact with both ClpP1 and ClpP2 so they can
degrade SsrA-tagged proteins, while ClpC1 could only interact
with ClpP2 for the degradation of a specific set of substrates. M.
tuberculosis ClpP2 interaction with ClpC1 has been previously
demonstrated, and RseA was shown to be targeted by the
ClpC1P2 complex [11,48], both confirming the formation of this
complex in the cell and also its ability to degrade specific untagged
proteins. We attempted to demonstrate protein-protein interac-
tions using two alternative bacterial two hybrid systems for all
combinations of ClpP and ATPase subunits (and accessory
proteins), but neither system allowed us to identify any interac-
tions. This is likely due to a limitation of such systems in detecting
interactions which form complexes, since we were also unable to
detect interactions between the E. coli subunits.
Recent work suggests that the functional proteolytic unit of the
Clp protease is comprised of both ClpP1 and ClpP2, with seven
subunits of each forming one of the two heptameric rings and that
neither ClpP1 nor ClpP2 are active when expressed independently
[6–7]. This contrasts with earlier work demonstrating that ClpP2
alone could form a functional protease with ClpC1 and effect
degradation of RseA [11]. Since both studies were conducted with
recombinant (tagged) proteins in vitro or using a surrogate host (M.
smegmatis), they may not truly reflect the intracellular setting in M.
tuberculosis. However, both studies demonstrate that the ClpP1 and
ClpP2 have different specificities, which is in agreement with our
findings.
The two ClpP subunits are co-expressed and are therefore
present in the cell under the same conditions. The specificity of the
two subunits seem however to be different; we propose that ClpP1
is involved in the degradation of SsrA-tagged proteins only, while
ClpP2 has a more general role in proteolysis being able to degrade
SsrA-tagged or untagged protein substrates.
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